341 related articles for article (PubMed ID: 27922635)
1. Increased plasma levels of circulating cell-free mitochondrial DNA in suicide attempters: associations with HPA-axis hyperactivity.
Lindqvist D; Fernström J; Grudet C; Ljunggren L; Träskman-Bendz L; Ohlsson L; Westrin Å
Transl Psychiatry; 2016 Dec; 6(12):e971. PubMed ID: 27922635
[TBL] [Abstract][Full Text] [Related]
2. Hypothalamic-pituitary-adrenal axis hyperactivity is associated with decreased brain-derived neurotrophic factor in female suicide attempters.
Ambrus L; Lindqvist D; Träskman-Bendz L; Westrin Å
Nord J Psychiatry; 2016 Nov; 70(8):575-81. PubMed ID: 27216156
[TBL] [Abstract][Full Text] [Related]
3. Suicidal intent and the HPA-axis characteristics of suicide attempters with major depressive disorder and adjustment disorders.
Lindqvist D; Träskman-Bendz L; Vang F
Arch Suicide Res; 2008; 12(3):197-207. PubMed ID: 18576201
[TBL] [Abstract][Full Text] [Related]
4. HPA axis hyperactivity and attempted suicide in young adult mood disorder inpatients.
Jokinen J; Nordström P
J Affect Disord; 2009 Jul; 116(1-2):117-20. PubMed ID: 19054569
[TBL] [Abstract][Full Text] [Related]
5. Salivary cortisol and suicidal behavior--a follow-up study.
Lindqvist D; Isaksson A; Träskman-Bendz L; Brundin L
Psychoneuroendocrinology; 2008 Sep; 33(8):1061-8. PubMed ID: 18672335
[TBL] [Abstract][Full Text] [Related]
6. Catecholamine and HPA axis dysfunction in depression: relationship with suicidal behavior.
Pitchot W; Reggers J; Pinto E; Hansenne M; Ansseau M
Neuropsychobiology; 2003; 47(3):152-7. PubMed ID: 12759559
[TBL] [Abstract][Full Text] [Related]
7. Blunted HPA Axis Activity in Suicide Attempters Compared to those at High Risk for Suicidal Behavior.
Melhem NM; Keilp JG; Porta G; Oquendo MA; Burke A; Stanley B; Cooper TB; Mann JJ; Brent DA
Neuropsychopharmacology; 2016 May; 41(6):1447-56. PubMed ID: 26450815
[TBL] [Abstract][Full Text] [Related]
8. Blunted HPA axis activity prior to suicide attempt and increased inflammation in attempters.
Melhem NM; Munroe S; Marsland A; Gray K; Brent D; Porta G; Douaihy A; Laudenslager ML; DePietro F; Diler R; Driscoll H; Gopalan P
Psychoneuroendocrinology; 2017 Mar; 77():284-294. PubMed ID: 28135675
[TBL] [Abstract][Full Text] [Related]
9. Leptin, Anxiety Symptoms, and Hypothalamic-Pituitary-Adrenal Axis Activity among Drug-Free, Female Suicide Attempters.
Ambrus L; Westling S
Neuropsychobiology; 2019; 78(3):145-152. PubMed ID: 31189176
[TBL] [Abstract][Full Text] [Related]
10. Vasopressin-neurophysin and DST in major depression: relationship with suicidal behavior.
Pitchot W; Scantamburlo G; Pinto E; Hansenne M; Reggers J; Ansseau M; Legros JJ
J Psychiatr Res; 2008 Jul; 42(8):684-8. PubMed ID: 17720191
[TBL] [Abstract][Full Text] [Related]
11. CSF 5-HIAA and DST non-suppression -independent biomarkers in suicide attempters?
Jokinen J; Mårtensson B; Nordström AL; Nordström P
J Affect Disord; 2008 Jan; 105(1-3):241-5. PubMed ID: 17499856
[TBL] [Abstract][Full Text] [Related]
12. High delta sleep-inducing peptide-like immunoreactivity in plasma in suicidal patients with major depressive disorder.
Westrin A; Ekman R; Träskman-Bendz L
Biol Psychiatry; 1998 May; 43(10):734-9. PubMed ID: 9606527
[TBL] [Abstract][Full Text] [Related]
13. HPA axis hyperactivity as suicide predictor in elderly mood disorder inpatients.
Jokinen J; Nordström P
Psychoneuroendocrinology; 2008 Nov; 33(10):1387-93. PubMed ID: 18805641
[TBL] [Abstract][Full Text] [Related]
14. Decreased corticotropin-releasing hormone (CRH) concentrations in the cerebrospinal fluid of eucortisolemic suicide attempters.
Brunner J; Stalla GK; Stalla J; Uhr M; Grabner A; Wetter TC; Bronisch T
J Psychiatr Res; 2001; 35(1):1-9. PubMed ID: 11287050
[TBL] [Abstract][Full Text] [Related]
15. CSF 5-HIAA, cortisol and DHEAS levels in suicide attempters.
Chatzittofis A; Nordström P; Hellström C; Arver S; Åsberg M; Jokinen J
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1280-7. PubMed ID: 23453639
[TBL] [Abstract][Full Text] [Related]
16. Suicidal subtypes, stress responsivity and impulsive aggression.
Stanley B; Michel CA; Galfalvy HC; Keilp JG; Rizk MM; Richardson-Vejlgaard R; Oquendo MA; Mann JJ
Psychiatry Res; 2019 Oct; 280():112486. PubMed ID: 31376789
[TBL] [Abstract][Full Text] [Related]
17. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.
Vreeburg SA; Hoogendijk WJ; van Pelt J; Derijk RH; Verhagen JC; van Dyck R; Smit JH; Zitman FG; Penninx BW
Arch Gen Psychiatry; 2009 Jun; 66(6):617-26. PubMed ID: 19487626
[TBL] [Abstract][Full Text] [Related]
18. Hyperactivity of the hypothalamic-pituitary-adrenal axis and mortality in major depressive disorder.
Coryell W; Young E; Carroll B
Psychiatry Res; 2006 May; 142(1):99-104. PubMed ID: 16631257
[TBL] [Abstract][Full Text] [Related]
19. HPA axis dysregulation in men with hypersexual disorder.
Chatzittofis A; Arver S; Öberg K; Hallberg J; Nordström P; Jokinen J
Psychoneuroendocrinology; 2016 Jan; 63():247-53. PubMed ID: 26519779
[TBL] [Abstract][Full Text] [Related]
20. Hypothalamic-pituitary-adrenal axis function and suicidal behavior in depression.
Roy A
Biol Psychiatry; 1992 Nov; 32(9):812-6. PubMed ID: 1450295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
